Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$980M |
| 2 |
Humana
HUM
|
+$637M |
| 3 |
Apple
AAPL
|
+$620M |
| 4 |
Home Depot
HD
|
+$541M |
| 5 |
Microsoft
MSFT
|
+$539M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$770M |
| 2 |
McDonald's
MCD
|
+$654M |
| 3 |
Cigna
CI
|
+$498M |
| 4 |
Digital Realty Trust
DLR
|
+$430M |
| 5 |
Amazon
AMZN
|
+$429M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.91% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2% |
| 4 | Industrials | 1.79% |
| 5 | Financials | 1.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5301
4D Molecular Therapeutics
FDMT
$743M
| $1.82M | ﹤0.01% |
143,220
+124,335
| +658% | +$2.08M |
|
5302
PUT
Paysafe
PSFE
$340M
| $1.82M | ﹤0.01% |
152,049
+20,074
| +15% | +$244K |
|
5303
PUT
Krystal Biotech
KRYS
$9.84B
| $1.82M | ﹤0.01% |
15,700
-13,800
| -47% | -$1.68M |
|
5304
State Street SPDR Portfolio High Yield Bond ETF
SPHY
$12.1B
| $1.82M | ﹤0.01% |
+81,219
| New | +$1.85M |
|
5305
CALL
Cimpress
CMPR
$2.24B
| $1.82M | ﹤0.01% |
26,000
+12,500
| +93% | +$827K |
|
5306
Franklin Intelligent Machines ETF
IQM
$97.5M
| $1.82M | ﹤0.01% |
+41,158
| New | +$1.94M |
|
5307
Pebblebrook Hotel Trust
PEB
$2.03B
| $1.82M | ﹤0.01% |
133,803
-322,144
| -71% | -$4.62M |
|
5308
PUT
MSC Industrial Direct
MSM
$6.92B
| $1.82M | ﹤0.01% |
18,500
+16,200
| +704% | +$1.6M |
|
5309
Vanguard Morningstar Small-Cap Growth ETF
VBK
$25B
| $1.81M | ﹤0.01% |
8,472
+5,666
| +202% | +$1.29M |
|
|
AVDL
5310
PUT
DELISTED
Avadel Pharmaceuticals
AVDL
| $1.81M | ﹤0.01% |
176,100
-75,700
| -30% | -$1.01M |
|
|
SILK
5311
CALL
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $1.81M | ﹤0.01% |
121,000
+115,500
| +2,100% | +$2.4M |
|
5312
PUT
United Natural Foods
UNFI
$2.92B
| $1.81M | ﹤0.01% |
128,200
-5,200
| -4% | -$102K |
|
5313
PUT
Jazz Pharmaceuticals
JAZZ
$15.9B
| $1.81M | ﹤0.01% |
14,000
-2,900
| -17% | -$386K |
|
|
RWT
5314
Redwood Trust
RWT
$603M
| $1.81M | ﹤0.01% |
253,989
+176,935
| +230% | +$1.3M |
|
5315
Tradr 1.25X NVDA Bear Daily ETF
NVDS
$12.9M
| $1.81M | ﹤0.01% |
3,047
+2,152
| +240% | +$1.25M |
|
|
HAPN
5316
CALL
Happen Inc
HAPN
$2.2B
| $1.81M | ﹤0.01% |
296,700
+125,800
| +74% | +$978K |
|
5317
Fiverr
FVRR
$316M
| $1.81M | ﹤0.01% |
73,932
-91,084
| -55% | -$2.56M |
|
5318
GeoPark
GPRK
$617M
| $1.81M | ﹤0.01% |
175,924
+16,960
| +11% | +$166K |
|
|
ITCI
5319
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.81M | ﹤0.01% |
34,700
+21,400
| +161% | +$1.25M |
|
|
AKRO
5320
CALL
DELISTED
Akero Therapeutics
AKRO
| $1.81M | ﹤0.01% |
35,700
+10,100
| +39% | +$470K |
|
5321
iShares Asia 50 ETF
AIA
$5.15B
| $1.8M | ﹤0.01% |
32,524
+32,468
| +57,979% | +$1.91M |
|
5322
Invesco Bloomberg Pricing Power ETF
POWA
$181M
| $1.8M | ﹤0.01% |
+27,523
| New | +$1.88M |
|
5323
ABM Industries
ABM
$2.79B
| $1.8M | ﹤0.01% |
45,065
-79,695
| -64% | -$3.45M |
|
5324
Carlyle Group
CG
$17.3B
| $1.8M | ﹤0.01% |
59,739
+52,065
| +678% | +$1.68M |
|
5325
PUT
Vista Energy
VIST
$7.93B
| $1.8M | ﹤0.01% |
59,200
+2,400
| +4% | +$62.8K |
|
Similar funds
Ken Griffin's Q3 2023 Portfolio in Review
As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.
By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
- Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
- Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
- Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
- Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
- Ken Griffin opened 1,406 new positions and closed 1,460 in Q3 2023.
- Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.
Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.